Advert - Moderna – Case AUTH/3746/2/23

• Date posted
  24 October 2024
• Sanction
  Advertisement,
• Case number/s
  AUTH/3746/2/23 - Complainant v Moderna

For promoting Spikevax (COVID-19 vaccine) in a manner that was inconsistent with its summary of product characteristics, Moderna was ruled in breach of the following clauses of the 2021 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 5.1 - Failing to maintain high standards
Clause 11.2 - Promoting a medicine in a manner that was inconsistent with its summary of product characteristics